Glucose management during and after intensive delivery room resuscitation

Jane E McGowan1, Jeffrey M Perlman

  • 1Division of Neonatology, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. jmcgowan@jhmi.edu

Insights

Hypoxic-ischemic encephalopathy (HIE) in newborns is a serious condition. Optimizing glucose levels after birth may help protect the infant brain from injury and improve outcomes.

Area of Science:

  • Neonatal neurology
  • Perinatal medicine
  • Neurocritical care

Background:

  • Hypoxic-ischemic encephalopathy (HIE) is a significant cause of infant mortality and long-term disability.
  • Delayed neuronal death following perinatal asphyxia contributes to brain injury.
  • Current management focuses on immediate post-resuscitation care to mitigate HIE.

Purpose of the Study:

  • To review existing evidence on the role of glucose in modifying brain injury after perinatal asphyxia.
  • To define optimal glucose management strategies for newborns following resuscitation.
  • To minimize delayed neuronal death and improve neurological outcomes in HIE.

Main Methods:

  • Systematic review of experimental and clinical studies.
  • Analysis of data on glucose levels and HIE outcomes.
  • Evaluation of interventions related to glucose management post-asphyxia.

Main Results:

  • Experimental data suggest neuroprotective effects of certain glucose interventions.
  • Evidence indicates a critical window for glucose management post-resuscitation.
  • Optimal glucose ranges require further definition to prevent both hypoglycemia and hyperglycemia.

Conclusions:

  • Glucose management is a crucial factor in mitigating hypoxic-ischemic brain injury.
  • Further research is needed to establish precise glucose targets for optimal neonatal HIE care.
  • Tailored glucose strategies may improve survival and reduce neurological deficits in affected infants.

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...